Company intelligence / Profile preview

ATMI

Danbury, Connecticut, United Statesatmi.com ↗

Ownership: Private
Development stage: Other

Overview

ATMI, Inc. was a technology company that provided solutions for both the semiconductor and life sciences industries, specializing in advanced materials and single-use bioprocess systems. The company ceased independent operations following its acquisition by Entegris Inc. in February 2014 for $1.15 billion. Prior to the main acquisition, its LifeSciences division was sold to Pall Corporation in December 2013 for $185 million.

Industry: Chemicals & Materials

Partnerships

Austar (joint venture for Asia-Pacific market)Artelis SA (acquired by ATMI in 2006 to expand single-use technology portfolio)

Beyond the preview

Go deeper on ATMI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATMI.

Explore the full profile